FDCA And Liability For State Failure-To-Warn Claims

Law360, New York (January 25, 2010, 11:43 AM EST) -- Federal law requires pharmaceutical manufacturers to obtain approval for drug products from the U.S. Food and Drug Administration prior to marketing. See Food, Drug and Cosmetic Act (“FDCA”), 21 U.S.C. § 301 et seq.

Pursuant to the FDCA, a manufacturer must show that the product is safe and effective for use under the conditions prescribed, recommended or suggested in the proposed labeling. 21 U.S.C. § 355, FDCA 52 Stat. 1040. Likewise, FDA approval for the labeling on pharmaceutical products must be obtained prior to marketing. Id....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.